An international workshop was sponsored by the World Health Organization to screen new antimycobacterial monoclonal antibodies and to identify antibodies which could be recommended as standard reagents giving consistent results under differing assay conditions. Fifty-eight antibodies were submitted to the workshop by eight independent laboratories. Nineteen of the antibodies recognized antigens distinct from those identified in earlier workshops, defining at least 10 new protein antigens. Monoclonal antibodies characterized in the workshop provide a set of convenient reagents for further characterization of mycobacterial antigens.
In 1984 and 1985, two international workshops sponsored by the World Health Organization Scientific Working Groups on the Immunology of Leprosy (IMMLEP) and Immunology of Tuberculosis (IMMTUB) evaluated the available murine monoclonal antibodies directed to mycobacterial antigens (3, 4) . After 55 antibodies were screened, five distinct protein antigens (subunit molecular masses of 65, 36, 35, 18, and 12 kDa), were identified in extracts from Mycobacterium leprae and seven antigens (71, 65, 38, 23, 19, 14 , and 12 kDa) were identified in extracts from Mycobacterium tuberculosis. The monoclonal antibodies were then used to screen recombinant DNA expression libraries, leading to the cloning of genes encoding the appropriate antigens and the opening -of a new era of molecular research in mycobacterial disease (15, 16) . Genes for almost all of these antigens have been characterized by nucleotide sequence analysis, and a substantial amount of information regarding the antigenicity and biochemistry of this set of mycobacterial proteins has been obtained (1, (13) (14) (15) (16) .
A striking feature of the workshops was the finding that although highly complex protein mixtures were used for immunization, there was extensive overlap in specificity of antibodies generated independently in different laboratories, thus prompting the idea that these antibodies defined the immunodominant antigens of the leprosy and tubercle bacilli. However, subsequent studies have demonstrated that while these initial proteins are certainly prominent targets of the immune response, many other mycobacterial antigens can be detected by using T lymphocytes, human sera, and additional antibodies (10, 13) . In particular, it was reported that generation of monoclonal antibodies in different inbred * Corresponding author. mouse strains (BALB.B10 or CBA/J instead of BALB/c) resulted in recognition of a novel repertoire of specificities (8) . In this report, we describe the results of a third workshop that was held in order to evaluate new monoclonal antibodies generated since the 1985 workshop.
Fifty-eight antimycobacterial monoclonal antibodies were submitted to the workshop by eight independent laboratories. These were coded and sent to two reference laboratories for screening by Western blot (immunoblot) assays and enzyme-linked immunosorbent assays (ELISAs). The results were collated in a third laboratory, and inconclusive or contradictory findings were repeated. Mycobacterial strains (see Table 1 , footnote b) were grown on Sauton's medium, and protein samples for immunoassay were prepared by two procedures: (i) bacteria were killed by heating at 75°C for 15 min, and extracts were prepared by ultrasonication in distilled water, and (ii) proteins were precipitated from culture media by addition of ammonium sulfate (80% saturation), resuspended in phosphate-buffered saline (pH 7.4) (PBS), and filtered through 0.2-,um-pore-size membranes. Protein extract from M. leprae (batch CD146) was supplied by R. J. W. Rees through the IMMLEP M. leprae Bank (National Institute for Medical Research, London, United Kingdom). For ELISAs, polystyrene microtiter plates with high binding capacity (Greiner, Nurtingen, Germany) were coated with 1 ,ug of sonicated antigen per well in PBS and incubated for 16 h at 4°C. The plates were washed with PBS containing 0.05% Tween 20 (PBST) and incubated for 1 h at 37°C with monoclonal antibodies diluted in 1% bovine serum albumin in PBST (culture supernatants were used at a dilution of 1:5, and ascitic fluids were used at 1:1,000). Antibody binding was detected by using peroxidase-conjugated sheep anti-mouse immunoglobulin G (IgG) (heavy plus light chains) (Institut Pasteur, Paris, France) diluted 1:1,000 
